Outcomes of Arterial Allografts Preserved at +2 to +8°C for Revascularization in Septic Settings

Résultats Des Allogreffes artérielles conservée à +2/+8°C Dans Les REvascularisations en MIlieu Septique

This study does not modify patient management or treatment. All patients undergoing treatment with an arterial allograft preserved at +2/+8°C as part of an arterial revascularization in a septic environment in either of the two centers between January 2024 and January 2025 will be included.

Imaging exams and clinical follow-up data will be analyzed. Reinterventions and causes of death will be recorded. All imaging required for the 6-month follow-up is routinely performed as part of standard care. No modification of patient management is planned.

Inclusion Criteria:

• Adult patient
• Requiring revascularization in a septic or high-risk septic environment
• With an estimated life expectancy of 12 months or more based on medical and surgical assessment
• Informed about the study

Exclusion Criteria:

• Pregnant women
• Individuals for whom regular medical follow-up cannot be ensured